𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation

✍ Scribed by Yeong-Hau H. Lien; Katherine Scott

Book ID
117443088
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
184 KB
Volume
35
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term survival and impact of ursodeo
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 275 KB πŸ‘ 2 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were

Long-term follow-up of a phase I study o
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
✍ Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris